A nonprofit institute where scientists, educators, and entrepreneurs translate the power of genomics into real world results to create a healthier more sustainable world.


Our Faculty

Richard M. Myers, PhD
Faculty Investigator


Visit Website

Ph.D. in Biochemistry, University of California Berkeley

Genomic and genetic analysis of human traits and diseases.

Richard Myers, PhD, is president and scientific director at HudsonAlpha. Myer’s lab focuses on applying functional genomics and genetics approaches to understanding how genes and regulatory regions contribute to basic biology, human disease, responses to the environment and population genetics.

Howard Jacob, PhD
Faculty Investigator


Visit Website

PhD in Pharmacology, University of Iowa

Genomics, common human disease
Howard Jacob, PhD, uses molecular genetics to understand complex, multifactorial disease. As executive vice president for genomic medicine at HudsonAlpha, Jacob brings together genome sequencing, bioinformatics and basic research to make a clinical diagnosis possible for patients.

David Bick, MD
Faculty Investigator


Visit Website

MD, George Washington University School of Medicine
Human clinical genetics

David Bick, MD, PhD, is a clinical geneticist with more than 20 years experience diagnosing and treating children with genetic disorders. Bick is the medical director of the Clinic for Genomic Medicine on the HudsonAlpha campus.

Devin Absher, PhD
Faculty Investigator


Visit Website

Ph.D. in Biochemistry and Molecular Biology, Emory University

Epigenomic analysis of cancer, autoimmune disorders, cardiovascular disease, psychiatric disorders and aging

Devin Absher, PhD, uses the epigenome to study complex diseases and traits, especially autoimmune disease, cardiovascular disease, cancer and aging.

Elizabeth Worthey, PhD
Faculty Investigator


Visit Website

PhD in Genetics/Genomics, Imperial College, London, UK

Clinical and translational use of genomic data
Liz Worthey, PhD, is the director of informatics at HudsonAlpha, providing tools to analyze genomic information.

Greg Barsh, MD, PhD
Faculty Investigator


Visit Website

M.D. and Ph.D. in pathology, University of Washington, Seattle

Genetic architecture of morphologic variation

Greg Barsh, PhD, MD, studies the genetic mechanisms that underlie differences in individual appearance and that could give new insight into both basic biology and human disease.

Greg Cooper, PhD
Faculty Investigator


Visit Website

Ph.D. in Genetics, Stanford University

Human Genetics and Genomics

Greg Cooper, PhD, researches the structures, functions and evolutionary histories of human genomes, with an emphasis on applying genomic approaches to study human disease.

Jane Grimwood, Ph.D.
Faculty Investigator


Visit Website

Ph.D. in Microbiology, University of Leeds, United Kingdom

Genomic resource development for plants

Jane Grimwood, PhD, co-directs the Genome Sequencing Center at HudsonAlpha, managing one of the few centers in the world that produces, analyzes and interprets genomic data on economically important plant and organism species to improve crop breeding and other agricultural practices.

Jeremy Schmutz
Faculty Investigator


Visit Website

B.S. in computer science, B.S. in biology, North Central College

Whole genome sequencing and assembly, population genomics

Jeremy Schmutz co-directs the Genome Sequencing Center at HudsonAlpha, managing one of the few centers in the world that produces, analyzes and interprets genomic data on economically important plant and organism species to improve crop breeding and other agricultural practices.

Jian Han, M.D., Ph.D.
Faculty Investigator


Visit Website

M.D., SuZhou Medical College, China; Ph.D. University of Alabama at Birmingham

Technology development to advance medical science

Jian Han, MD, PhD, focuses on developing integrated solutions for molecular differential diagnosis and mapping the personalized immunorepertoire.

Jozef Lazar, MD, PhD
Faculty Investigator


Visit Website

MD, Comenius University, Martin, Czechoslovakia

PhD in Physiology, Comenius University, Bratislava, Czechoslovakia

Genomics, Common Human Diseases
The ultimate goal for personalized genomic medicine is tailoring treatment. Because we expect the majority of patients to have a unique sequence variant, tailoring treatment for patients with rare disease will require validation nominated sequence variants using different molecular biology approaches. In the validation process, the Lazar lab will utilize primary patients or commercially available human cell lines for different cellular assays or vertebrate model system using gene editing to generate and functionally test the variant of interest. The goal of Lazar’s work is to develop a functional screening program to rapidly test variants or genes identified in individual clinical cases and testing potential treatment modalities

Kimberly Strong, PhD
Faculty Investigator


Visit Website

PhD in Bioethics, University of Sydney, Sydney, NSW Australia

Genomics and Ethics
Kim Strong, PhD, is a genetics-trained bioethicist, a scientist who studies the application and limits of empirical ethics, particularly as it relates to contentious and emerging genetic technologies.

Neil Lamb, PhD
Faculty Investigator


Visit Website

Ph.D. in Genetics and Molecular Biology, Emory University

Educational outreach relating to genetics, genomics and biotechnology

Neil Lamb, PhD, oversees all educational programming developed at HudsonAlpha as vice president for educational outreach. Lamb creates innovative teacher training, student experiences, public enrichment, classroom kits and digital resources that re-shape how science education is delivered.

Sara Cooper, Ph.D.
Faculty Investigator


Visit Website

Ph.D. in Genetics, Stanford University


Sara Cooper, PhD, focuses on combining metabolomics with genomics and applying that data to pancreatic and ovarian cancer.  

Shawn Levy, Ph.D.
Faculty Investigator


Visit Website

Ph.D. in Biochemistry, Emory University

Technology development and automation, informatics, genomic variation

Shawn Levy, PhD, uses high performance genotyping and sequencing technologies to support projects from plant and animal phylogenetic studies to translational and clinical based projects at the Genomic Services Laboratory and the Clinical Services Laboratory.

Our Genomic Research

Since opening its doors in 2008, HudsonAlpha has further secured its role as a global leader in biotechnology and genomic research. We’ve made discoveries in ALS, childhood genetic disorders and kidney cancer; expanded research in bipolar and schizophrenia and continued critical research in other devastating conditions, including cancer, Parkinson’s, lupus, multiple sclerosis and more.

RT @song_ofthesouth: Economic Impact of @HudsonAlpha exceeds 1.3B since inception. #Huntsville #biotech t.co/yuQXiS9wKS



Color Skin